Balchem Corp (BCPC) Stock: Price, Forecast & Analyst Target
Balchem Corp (BCPC) — MoonshotScore 89/100 (Exceptional band), calculated Nov 18, 2026. Price $168.73 (-0.53%), as of the Nov 18, 2026 trading session; market cap $5.36B. Expected results Feb 19, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Balchem Corp · BCPC · NASDAQ · Basic Materials · Chemicals - Specialty
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.
Price as of Nov 18, 2026
Key Statistics
MoonshotScore v2 · Balchem (BCPC)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality, a fortress balance sheet and durable growth, but an expensive valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Fortress; Valuation: Rich; Growth Durability: Compounding; Momentum: Surging.
Enterprise value relative to EBITDA is the main valuation drag relative to sector peers.
- EPS beat 0 of the last 4 reports
- Altman Z 10.87 · Piotroski F 8
- ROE 13.0% · ROA 8.5% · current ratio 2.47
Holding back: a rich price
Helping: business quality, balance-sheet strength, durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 86 | Exceptional | |
| 86 | Exceptional | |
| 85 | Exceptional | |
| 85 | Exceptional | |
| 89 | Exceptional | |
| 89 | Exceptional |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $168.73 | |
| Change on the day | -0.53% | |
| 52-week range | $147.18–$186.15 | |
| Market capitalisation | $5.36B | — |
| Price / earnings (trailing) | 31.77 | |
| Shares traded on the day | 208.9K | |
| Beta (volatility vs the S&P 500) | 0.85 |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
How to read these dates
Estimated dates can change.
Other perspectives
Council score for Balchem (BCPC): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 17, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Balchem (BCPC), and what does it report?
Short answer
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. Balchem Corp (BCPC) is listed on NASDAQ. Basic Materials / Chemicals Specialty SEC filing business address: Montvale, NJ. It employs 1,430 people and is led by Theodore L. Harris. The market values it at $5.36B.
What do the latest results show for Balchem (BCPC)?
Short answer · as of
Against analyst estimates the company has EPS beat 0 of the last 4 reports.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
| Sep 30, 2025 | Not available | Not available | Not available | Not available |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $290.66M Oct 23, 2026
- Latest report · revenue estimate
- $289.25M Oct 23, 2026
- Latest report · revenue vs estimate
- Above estimate Oct 23, 2026
- Latest report · EPS vs estimate
- Above estimate Oct 23, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Oct 23, 2026 | $290.66M | $289.25M | $1.5700 | $1.4300 |
| Jul 31, 2026 | $284.00M | $268.50M | $1.4000 | $1.2700 |
| Apr 30, 2026 | $270.71M | $266.50M | $1.2500 | $1.3300 |
| Feb 20, 2026 | $263.62M | $259.59M | $1.3100 | $1.2900 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Jun 2025 | $255M | $38M | — |
| Sep 2025 | $268M | $40M | $1.24 (diluted) |
| Q4 FY2025 | $264M | $39M | $1.21 (diluted) |
| Q1 FY2026 | $271M | $40M | $1.25 (diluted) |
What are the financial strengths and risks for Balchem (BCPC)?
Short answer
Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway. The MoonshotScore pillars rate business quality, balance-sheet strength, durable growth, positive momentum as strengths. What is holding it back is a rich price. The distress and quality screens read Altman Z 10.87 · Piotroski F 8. Trailing ratios: ROE 13.0% · ROA 8.5% · current ratio 2.47.
Data-derived red flags
- Inconsistent delivery — missed Wall Street EPS estimates in 0 of the last 4 reported quarters.
- Rich valuation — a P/E of 31.77 runs well above the Basic Materials sector’s ~19.90x, leaving little room for a miss.
What should you watch next at Balchem (BCPC)?
Short answer · as of
The next earnings report is expected on Feb 19, 2027. Current published price targets run low $210.00 · high $215.00 · consensus $212.50 · median $212.50 against a quoted price of $168.73 (as of Nov 18, 2026).
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
Checked against the records this page reads, on the dates shown above.
How does Balchem compare with its peers?
Short answer
Balchem's score ranks 4th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| $24.19 Nov 18, 2026 | $4.83B | 98 5-pillar Nov 18, 2026 | |
| $222.03 Nov 18, 2026 | $2.97B | 93 5-pillar Nov 18, 2026 | |
| $12.09 Nov 18, 2026 | $7.75B | 91 5-pillar Nov 18, 2026 | |
| Balchem (BCPC) — this page | $168.73 | $5.36B | 89 |
| $703.23 Nov 18, 2026 | $6.47B | 80 5-pillar Nov 18, 2026 | |
| $153.20 Nov 18, 2026 | $3.19B | 76 5-pillar Nov 18, 2026 | |
| $36.46 Nov 18, 2026 | $7.80B | 69 5-pillar Nov 18, 2026 | |
| $74.03 Nov 18, 2026 | $3.80B | 66 5-pillar Nov 18, 2026 | |
| $28.38 Nov 18, 2026 | $7.41B | 65 5-pillar Nov 18, 2026 | |
| $117.59 Nov 18, 2026 | $5.00B | 65 5-pillar Nov 18, 2026 | |
| $76.39 Nov 18, 2026 | $3.50B | 65 5-pillar Nov 18, 2026 | |
| $44.34 Nov 18, 2026 | $4.07B | 64 5-pillar Nov 18, 2026 | |
| $62.36 Nov 18, 2026 | $7.13B | 63 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $210.00 – $215.00
- Consensus target
- $212.50
- Median target
- $212.50
Consensus record · Captured .
Measured against a quoted price of $168.73 (as of Nov 18, 2026).
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 12
- Identified insiders
- 8
- Purchases
- 0
- Sales
- 0
- Other transactions
- 12
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held BCPC in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported BCPC in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Balchem (BCPC)?
Common Questions About BCPC (Basic Materials)
These answers are editorial: 1 of these 9 answers is drawn from the BCPC research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for BCPC?
BCPC carries the MoonshotScore stated above — the Exceptional band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Is BCPC a good stock to buy?
Stock Expert AI does not rate BCPC buy, sell or hold. Balchem Corp carries a MoonshotScore, in the Exceptional band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the BCPC stock price today?
The last price recorded for Balchem Corp (BCPC), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the BCPC price target?
The analyst consensus price target for Balchem Corp (BCPC), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
What do analysts say about BCPC stock?
Analyst coverage of Balchem Corporation (BCPC) typically focuses on its growth prospects, profitability, and competitive positioning within the specialty chemicals industry. Key valuation metrics include the P/E ratio, profit margin, and gross margin.
What are the key factors to evaluate for BCPC?
Balchem Corp (BCPC) holds a MoonshotScore in the high range. To weigh it, compare the trailing P/E under Price & valuation with the analyst view under Analyst targets & estimates on this page. Strategic Acquisitions and Partnerships: Balchem can pursue strategic acquisitions and partnerships to expand its product portfolio and geographic reach. Not financial advice.
How frequently does BCPC data refresh on this page?
BCPC's price is the last quote we recorded, from the Nov 18, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven BCPC's recent stock price performance?
Balchem Corp (BCPC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BCPC overvalued or undervalued right now?
The trailing P/E of Balchem Corp (BCPC) is listed under Price & valuation, and the analyst consensus target under Analyst targets & estimates, on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 47 figures on this page — 1 from SEC filings and earnings calls, 39 from Financial Modeling Prep (FMP), 3 with no recorded source, 2 computed by us, formula shown in the register and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com